Strategic Desmoid Tumor Education and Access
Discover how medical institutions provide education on desmoid tumors, ensuring patient referrals and expanding access to innovative therapies.
Stay updated with breaking news from Peer Exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Discover how medical institutions provide education on desmoid tumors, ensuring patient referrals and expanding access to innovative therapies.
Experts delve into the fundamentals of gene therapy, covering in vivo and ex vivo methods, and explore cellular function targets for effective treatment of a disease.
Experts discuss the CLEOPATRA trial outcomes, taxane nuances, and evolving strategies in first-line treatment. They review practical considerations and ongoing trials and dive into the dynamic landscape of managing metastatic HER2+ breast cancer, anticipating transformative developments.
Jessica Nance, MD, MS, discusses maximizing gene therapy efficiency by selecting vectors for gene size, tissue targeting, and low exposure, and focusing on precise promoters for expression.
Experts delve into post–KATHERINE trial discussions, examining data and its impact on residual disease. They highlight unmet needs, emphasizing the ongoing CompassHER2 RD trial’s potential to address challenges, especially regarding brain metastases.